Fiduciary Alliance’s GeoVax Labs GOVX Stock Holding History

Fiduciary Alliance’s Portfolio GOVX Stock Details GOVX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-58	Closed	-$5.98K	–	560
2025 Q4	$5.98K	Buy	+58	New	+$15.3K	﹤0.01%	508

Other funds holding GOVX

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Fiduciary Alliance's GOVX Position: Q1 2026 in Review

Fiduciary Alliance sold out of GeoVax Labs (GOVX) in Q1 2026, closing a stake of 58 shares — an estimated $5.98K sold.

Fiduciary Alliance first reported a position in GOVX in Q4 2025 and held it in 1 quarter. The position peaked at $5.98K in Q4 2025. 10 funds tracked by Wall St. Rank hold GOVX as of Q1 2026.

Fiduciary Alliance reported no remaining GeoVax Labs position as of Q1 2026 after selling out during the quarter.
Fiduciary Alliance sold 58 GeoVax Labs shares in Q1 2026, an estimated $5.98K.
Fiduciary Alliance first reported a position in GeoVax Labs in Q4 2025 and held it in 1 quarter.
Fiduciary Alliance's GeoVax Labs position peaked at $5.98K in Q4 2025.
10 funds tracked by Wall St. Rank held GeoVax Labs as of Q1 2026.

Based on Fiduciary Alliance's 13F filing for Q1 2026, filed 20 Apr 2026.